Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pracinostat + Azacitidine in High-Risk MDS
NCT01873703Phase 2Completed
- Sponsor
- Helsinn
- Start
- Jun 2013
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pracinostat in myelodysplastic syndrome (MDS), sponsored by Helsinn. Started Jun 2013; status: completed.
02
Drugs
pracinostat
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT01873703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01873703.